Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Tirzepatide (Zepbound and Mounjaro) is FDA-approved and available by prescription, with Phase 3 data showing up to 20.9% weight loss at 72 weeks
Initial loss in the first 4 weeks comes mostly from gastric effects
Explicit marketing towards GLP-1 users may therefore be a mistake, as that risks turning off others who are also looking for products that are nutrient dense, high protein, etc, but who may think the product being marketed is not for them
Healthcare System Implications The widespread adoption of GLP-1 medications presents both opportunities and challenges for healthcare systems: a) Cost-Benefit Calculations : Although the medications themselves are expensive (ranging from $900 to $1,300 monthly without insurance coverage), their potential to reduce obesity-related healthcare costs is substantial
US$ 21.11
US$ 26.40
US$ 27.24
US$ 23.62
US$ 21.31
